How healthcare and pharma are fighting the COVID-19 war Laurie Don Laurie Don examines how companies held by the Liontrust Sustainable Investment team are contributing to the fight against Coronavirus, from providing PPE equipment and helping towards vaccines, to re-purposing drugs already in the market. Read more Unbottling the gene genie Laurie Don Gene therapy has the potential to transform the healthcare sector of the future. Laurie Don explains how, and what are the opportunities for investors. Read more Cannabinoid approval supports GW’s strategy Laurie Don With GPs now able to prescribe two cannabis-based medicines from GW Pharmaceuticals, Laurie Don runs the rule over this long-term holding in the Liontrust SF Funds. Read more Alzheimer's: new research provides big opportunities Laurie Don Laurie Don, Investment Manager at ATI, discusses the potential investment opportunities in companies trialling new treatments for Alzheimer’s disease. Read more